Breast cancer begins in the breast, typically as a ductal carcinoma and can affect men or women. It is the second most commonly diagnosed cancer of women in the United States. Risk for developing breast cancer increases with age, family history, gene mutations on BRCA1 and BRCA2, obesity, radiation exposure, early onset of puberty, never having kids, postmenopausal hormone therapy, and excessive alcohol intake. Treatment for breast cancer includes: surgery, radiation therapy, chemotherapy, hormone therapy, alternative medicine, and various medications. Bilateral breast cancer occurs when the cancer has developed in both breasts. Research indicates that the 10-year recurrence rate for stage I bilateral breast cancer is nearly twice as high as that of stage I unilateral breast cancer.
Bilateral Breast Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Bilateral Breast Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 2606 products for the study of Bilateral Breast Cancer that can be applied to Chromatin Immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.